|
PPP2R5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.90769999994534E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.802050E-04 |
| Normal-vs-Stage2 |
1.133790E-02 |
| Normal-vs-Stage3 |
7.57829999999959E-05 |
| Normal-vs-Stage4 |
1.415290E-03 |
| Stage1-vs-Stage2 |
5.684400E-01 |
| Stage1-vs-Stage3 |
4.435600E-01 |
| Stage1-vs-Stage4 |
6.823600E-01 |
| Stage2-vs-Stage3 |
3.051800E-01 |
| Stage2-vs-Stage4 |
4.653800E-01 |
| Stage3-vs-Stage4 |
8.853400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70659999998435E-06 |
| Normal-vs-AfricanAmerican |
7.518900E-03 |
| Normal-vs-Asian |
2.475000E-03 |
| Caucasian-vs-AfricanAmerican |
8.370600E-01 |
| Caucasian-vs-Asian |
4.934200E-01 |
| AfricanAmerican-vs-Asian |
7.749600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.679400E-03 |
| Normal-vs-Female |
4.97330000004403E-06 |
| Male-vs-Female |
8.788000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.388440E-04 |
| Normal-vs-Age(41-60Yrs) |
6.01639999999737E-05 |
| Normal-vs-Age(61-80Yrs) |
1.160770E-03 |
| Normal-vs-Age(81-100Yrs) |
3.435800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.503800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.507400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.007000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.628600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.477400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.823200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.247700E-02 |
| Classical-VS-Follicular |
3.443600E-01 |
| Classical-VS-Other |
4.771800E-01 |
| Classical-VS-Normal |
3.044900E-04 |
| Tall-VS-Follicular |
2.469900E-02 |
| Tall-VS-Other |
7.546600E-01 |
| Tall-VS-Normal |
1.83544999999841E-05 |
| Follicular-VS-Other |
3.596600E-01 |
| Follicular-VS-Normal |
1.886110E-02 |
| Other-VS-Normal |
2.500100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.755490E-04 |
| Normal-vs-N1 |
1.12469999979936E-08 |
| N0-vs-N1 |
1.177940E-02 |
|
|
